Antoinette R Tan
15PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Mar 11, 2026
ToPCourT protocol: a phase II trial of Trilaciclib, Pembrolizumab, gemcitabine, and Carboplatin in locally advanced/unresectable or metastatic Triple-negative breast cancer.Megan B Sears-Smith, Ashley Matusz-Fisher, James T Symanowski
|Jan 31, 2025
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers.Arielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe
|Dec 05, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy.Rani Bansal, Tolulope Adeyelu, Andrew Elliott
|Nov 12, 2024
Interpretation of Reports and Translation to Community Oncologists: An Overview of Approaches.Carol J Farhangfar, Kathryn F Mileham, Antoinette R Tan
|Oct 15, 2024
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study.Erika Hamilton, Matthew D Galsky, Sebastian Ochsenreither
|Sep 03, 2024
Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer.Kaitlyn O'Keefe, Neelam V Desai, Antoinette R Tan
Pageof 3
Frequent Collaborators
2 joint publications
George W Sledge
2 joint publications
Arielle L Heeke
2 joint publications
Joyce O'Shaughnessy
2 joint publications
James T Symanowski
2 joint publications
John S Yi
2 joint publications
Hope S Rugo
1 joint publications
Ashley Matusz-Fisher
1 joint publications
Anton I Rosenbaum
1 joint publications
Gail S Wright
1 joint publications
Lazar Popovic
